Evidence for induced microsomal bilirubin degradation by cytochrome P450 2A5

被引:42
作者
Abu-Bakar, A
Moore, MR
Lang, MA
机构
[1] Univ Queensland, Natl Res Ctr Environm Toxicol, Coopers Plains, Qld, Australia
[2] Queensland Hlth Sci Serv, Brisbane, Qld, Australia
[3] Uppsala Univ, Div Biochem, Dept Pharmaceut Biosci, Uppsala, Sweden
关键词
cadmium; cytochrome P450 2A5; alternative pathway of bilirubin degradation; haem oxygenase 1; oxidative stress; bilirubin;
D O I
10.1016/j.bcp.2005.08.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Oxidative metabolism of bilirubin (BR) - a breakdown product of haem with cytoprotective and toxic properties - is an important route of detoxification in addition to glucuronidation. The major enzyme(s) involved in this oxidative degradation are not known. In this paper, we present evidence for a major role of the hepatic cytochrome P450 2A5 (Cyp2a5) in BR degradation during cadmium intoxication, where the BR levels are elevated following induction of haem oxygenase-1 (HO-1). Treatment of DBA/2J mice with CdCl2 induced both the Cyp2a5 and HO-1, and increased the microsomal BR degradation activity. By contrast, the total cytochrome P450 (CYP) content and the expression of Cyp1a2 were down-regulated by the treatment. The induction of the HO-1 and Cyp2a5 was substantial at the mRNA, protein and enzyme activity levels. In each case, the up-regulation of HO-1 preceded that of Cyp2a5 with a 5-10 h interval. BR totally inhibited the microsomal Cyp2a5-dependent coumarin hydroxylase activity, with an IC50 approximately equal to the substrate concentration. The 7-methoxyresorufin 7-O-demethylase (MROD) activity, catalyzed mainly by the Cyp1a2, was inhibited up to 36% by BR. The microsomal BR degradation was inhibited by coumarin and a monoclonal antibody against the Cyp2a5 by about 90%. Furthermore, 7-methoxyresorufin, a substrate for the Cyp1a2, inhibited BR degradation activity by approximately 20%. In sum, the results strongly suggest a major role for Cyp2a5 in the oxidative degradation of BR. Secondly, the coordinated up-regulation of the HO-1 and Cyp2a5 during Cd-mediated injury implicates a network of enzyme systems in the maintenance of balancing BR production and elimination. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1527 / 1535
页数:9
相关论文
共 57 条
[1]   Acute cadmium chloride administration induces hepatic and renal CYP2A5 mRNA, protein and activity in the mouse: involvement of transcription factor NRF2 [J].
Abu-Bakar, A ;
Satarug, S ;
Marks, GC ;
Lang, MA ;
Moore, MR .
TOXICOLOGY LETTERS, 2004, 148 (03) :199-210
[2]  
ALEXIDIS AN, 1994, RES COMMUN MOL PATH, V85, P67
[3]   Regulation of the Cyp2a5 gene involves an aryl hydrocarbon receptor-dependent pathway [J].
Arpiainen, S ;
Raffalli-Mathieu, F ;
Lang, MA ;
Pelkonen, O ;
Hakkola, J .
MOLECULAR PHARMACOLOGY, 2005, 67 (04) :1325-1333
[4]   CHEMISTRY AND BIOLOGY OF HEME - EFFECT OF METAL-SALTS, ORGANOMETALS, AND METALLOPORPHYRINS ON HEME-SYNTHESIS AND CATABOLISM, WITH SPECIAL REFERENCE TO CLINICAL IMPLICATIONS AND INTERACTIONS WITH CYTOCHROME-P-450 [J].
BERI, R ;
CHANDRA, R .
DRUG METABOLISM REVIEWS, 1993, 25 (1-2) :49-152
[5]   EVIDENCE FOR CONVERSION OF BILIRUBIN TO DIHYDROXYL DERIVATIVES IN GUNN RAT [J].
BERRY, CS ;
ZAREMBO, JE ;
OSTROW, JD .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1972, 49 (05) :1366-&
[6]  
BURKE MD, 1974, DRUG METAB DISPOS, V2, P583
[7]   Liver injury and expression of cytochromes P450: Evidence that regulation of CYP2A5 is different from that of other major xenobiotic metabolizing CYP enzymes [J].
CamusRandon, AM ;
Raffalli, F ;
Bereziat, JC ;
McGregor, D ;
Konstandi, M ;
Lang, MA .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1996, 138 (01) :140-148
[8]  
Chemin I, 1996, HEPATOLOGY, V24, P649, DOI 10.1002/hep.510240330
[9]   Altered expression of hepatic carcinogen metabolizing enzymes with liver injury in HBV transgenic mouse lineages expressing various amounts of hepatitis B surface antigen [J].
Chemin, I ;
Ohgaki, H ;
Chisari, FV ;
Wild, CP .
LIVER, 1999, 19 (02) :81-87
[10]   Distinct time courses of increase in cytochromes P450 1A2, 2A5 and glutathione S-transferases during the progressive hepatitis associated with Helicobacter hepaticus [J].
Chomarat, P ;
Sipowicz, MA ;
Diwan, BA ;
Fornwald, LW ;
Awasthi, YC ;
Anver, MR ;
Rice, JM ;
Anderson, LM ;
Wild, CP .
CARCINOGENESIS, 1997, 18 (11) :2179-2190